5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.53▲ | 7.53▲ | 7.53▲ | 8.08▲ | 7.79▲ |
MA10 | 7.49▲ | 7.47▲ | 7.47▲ | 7.75▲ | 7.83▲ |
MA20 | 7.50▲ | 7.54▲ | 7.54▲ | 7.42▲ | 7.82▲ |
MA50 | 7.56▲ | 7.69▲ | 7.67▲ | 7.61▲ | 8.49▲ |
MA100 | 7.69▲ | 7.74▲ | 7.75▲ | 7.66▲ | 19.38▼ |
MA200 | 7.89▲ | 8.07▼ | 8.49▼ | 8.47▲ | 241.51▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.031▲ | 0.032▲ | 0.033▲ | 0.129▲ | 0.184▲ |
RSI | 57.307▲ | 56.556▲ | 56.466▲ | 61.813▲ | 51.722▲ |
STOCH | 49.390 | 51.523 | 51.523 | 79.757 | 42.607 |
WILL %R | 0.000▲ | -16.484▲ | -16.484▲ | -0.926▲ | -38.063 |
CCI | 177.305▲ | 220.002▲ | 220.002▲ | 178.080▲ | 153.994▲ |
Wednesday, April 30, 2025 03:51 AM
2-Year U.S. Treasury Note Continuous Contract $104.082 0.078 0.08% 5-Year U.S. Treasury Note Continuous Contract $109.227 0.133 0.12% 10-Year U.S. Treasury Note Continuous Contract $112.266 0.109 ...
|
Saturday, April 26, 2025 12:05 AM
Despite a successful Neurosterix spinout and a strong patent position, Addex Therapeutics Ltd (ADXN) faces financial hurdles with reduced revenue and the need for additional funding.
|
Friday, April 25, 2025 02:40 PM
Hello everyone. I would like to thank you all for attending our 2024 Full Year Financial Results Conference Call. I'm here with Mikhail Kalinichev, our Head of Translational Science, who will ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 8.5725 | 8.5725 | 8.5725 | 8.5725 | 842 |
30/04/25 | 8.30 | 8.59 | 7.7922 | 7.7922 | 2,341 |
29/04/25 | 7.90 | 7.90 | 7.90 | 7.90 | 13,394 |
28/04/25 | 8.00 | 8.00 | 8.00 | 8.00 | 1,779 |
25/04/25 | 8.19 | 8.19 | 7.9701 | 8.16 | 2,511 |
24/04/25 | 7.60 | 7.60 | 7.60 | 7.60 | 1,203 |
23/04/25 | 7.60 | 7.60 | 7.60 | 7.60 | 826 |
22/04/25 | 7.45 | 8.20 | 7.44 | 7.635 | 3,950 |
21/04/25 | 7.30 | 7.50 | 6.75 | 6.75 | 3,968 |
17/04/25 | 7.30 | 7.50 | 7.29 | 7.50 | 3,864 |
|
|
||||
|
|
||||
|
|